ReviewPhysical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature
Introduction
Advances in diagnosis and treatment have rendered breast cancer a chronic disease in countries with modern health care. For example, the American Cancer Society estimates that 89% of US women diagnosed with invasive breast cancer in 2009–2010 will be alive 5 years after diagnosis and 82% will be alive 10 years after diagnosis [1]. The National Cancer Institute estimates that approximately 2.5 million women with a history of breast cancer were alive in January 2006. However, little is known about lifestyle factors that modify breast cancer prognosis. Given the increasing numbers of long-term survivors, research specific to prevention of recurrence, new breast cancer events, and mortality is of considerable public health importance.
There are numerous reviews and meta-analyses addressing lifestyle and incident cancer. The most comprehensive and detailed synthesis of the scientific evidence regarding the extent to which lifestyle could modify the risk of cancer was published in 2007: Report on Food, Nutrition, Physical Activity and the Prevention of Cancer: a global perspective [2]. For this report, an expert panel was convened to assess and judge the evidence. The panel produced a set of public health goals and recommendations as follows:
- 1.
Be as lean as possible within the normal range of body weight.
- 2.
Be physically active as part of everyday life.
- 3.
Limit consumption of energy-dense foods and avoid sugary drinks.
- 4.
Eat mostly foods of plant origin.
- 5.
Limit intake of red meat and avoid processed meat.
- 6.
Limit alcoholic drinks.
- 7.
Limit consumption of salt and avoid mouldy cereals (grains) or pulses (legumes).
- 8.
Aim to meet nutritional needs through diet alone.
The expert panel also concluded that the evidence on survivorship was not clear enough to make firm judgments. Therefore, a special recommendation was made for cancer survivors indicating that they should follow the recommendations for cancer prevention.
In addition to the general recommendations given above for all cancers, this 2007 report reviewed the evidence regarding lifestyle and breast cancer. The panel considered the evidence for pre-menopausal cancer separately from post-menopausal cancer. For pre-menopausal breast cancer, the panel concluded the evidence was convincing that alcoholic drinks increased risk, probable that body fatness increased risk, and suggestive that low physical activity increased the risk of cancer. For post-menopausal cancer, the panel concluded that the evidence was convincing that alcoholic drinks and fatness increased risk; probable that low physical activity, abdominal fatness, and adult weight gain increased risk; and suggestive that total dietary fat increased risk of cancer. Overall, evidence regarding dietary factors (with the exception of total fat) was deemed limited.
There is considerable research on mechanisms for how lifestyle factors could influence breast cancer, although it is generally not specific to survivorship. Breast cancer is hormone related and the association between endogenous sex hormone concentrations and breast cancer risk in post-menopausal women is well-established. In particular, a recent meta-analysis reported that estradiol was associated with a 2- to 3-fold increased risk of breast cancer (p < 0.01) [3]. Chronic hyperinsulinemia is associated with increased availability of IGF-1 and concomitant changes in the cellular environment that favor tumor formation. Epidemiologic studies have shown a consistent, positive association of fasting insulin concentrations or type 2 diabetes mellitus with incident [4], [5] and recurrent breast cancer [6], [7]. Finally, inflammation in the tumor microenvironment appears to aid in the proliferation and survival of malignant cells, promote angiogenesis and metastasis, subvert adaptive immune responses, and alter responses to hormones and chemotherapeutic agents [8]. Dozens of circulating markers of inflammation have been identified, including adiponectin, IL-6, and TNF-α. High-sensitivity C-reactive protein (CRP) is a general marker of chronic inflammation at the vascular level that has been investigated extensively in relation to cardiovascular disease [9], [10], [11], [12] and more recently associated with increased cancer risk [13]. Notably, one recent study found that elevated CRP was associated with reduced survival in breast cancer patients [14].
Although the data are conflicting, research indicates that lifestyle can influence the mechanisms summarized above. In particular, obesity has been consistently correlated with higher concentrations of estradiol, fasting insulin, and inflammatory markers [15]. Randomized trials have shown that increased physical activity and diets low in fat and high in vegetables and fruit reduce circulating levels of estradiol and estrone [16], [17]. Physical activity, hypocaloric diets, and possibly low-glycemic diets may reduce fasting insulin levels [18]. Physical activity and dietary patterns characterized as Mediterranean, anti-inflammatory, or having a low glycemic load have been associated with reductions in CRP [19], [20]. These associations of obesity, physical activity, and diet with breast cancer markers suggest that lifestyle has the potential to modify breast cancer risk.
The objective of this report is to present a review of the epidemiologic research on physical activity, diet, and adiposity with breast cancer clinical outcomes among women with a history of breast cancer.
Section snippets
Methods
We conducted a bibliographic database search for randomized controlled trials, cohort studies, or case-control studies of breast cancer outcomes that contained the words “breast cancer” plus “recurrence,” “mortality” or “survival” plus keywords related to the exposures of interest (e.g., “alcohol,” “diet,” “obesity”). We searched the bibliographies of publications for other relevant studies. We included all studies published in the prior 10 years (1999–2009) as well as a few large studies
Observational studies of physical activity, diet and obesity and breast cancer outcomes
Table 1 gives details regarding the observational studies of lifestyle and breast cancer outcomes. Specifically, we present the reference, sample size, number and type of events, years of follow-up, menopausal status of the participants, and the specific exposures. Information from this table supplements the summary data (HR and CI) presented in the forest plots.
Observational studies of physical activity
We identified four studies of physical activity and additional breast cancer events [22], [23], [24], [25] (Fig. 1). None of these
Discussion
The most consistent finding from the observational studies was the increased risk of adiposity or body fatness in relation to mortality. We found a nearly 30% increased risk for both post- and pre-diagnosis adiposity. Although the observational data were not as consistent (or abundant), physical activity appears to be associated with a 30% decreased risk of mortality. Data from 7 cohort studies did not suggest that alcoholic drinks are a risk factor.
Based on observational studies, total dietary
Conflict of interest
All authors (Patterson, Cadmus, Emond, Pierce) declare that they have no conflicts of interest.
Funding
Funding for this study was supported by a gift from The Safeway Foundation. The funding source was not involved in the study design, collection, analysis, and interpretation of data, writing the report, or the decision to submit the paper for publication.
Contributors
Drs. Patterson, Cadmus and Pierce were responsible for the manuscript design and analysis plan, interpretation of the analysis, and drafting and reviewing the article for important intellectual content. Ms. Emond performed the statistical analysis and reviewed the article for intellectual content.
Provenance and peer review
Commissioned and externally peer reviewed.
References (71)
- et al.
Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status
Endocrinol Metab Clin North Am
(2004) - et al.
A new dietary inflammatory index predicts interval changes in serum high-sensitivity C-reactive protein
J Nutr
(2009) - et al.
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience
Ann Oncol
(2004) - et al.
Body mass index and breast cancer survival in relation to the introduction of mammographic screening
Eur J Surg Oncol
(2009) - et al.
A randomized trial of the effect of a plant-based dietary pattern on additional breast cancer events and survival: the Women's Healthy Eating and Living (WHEL) Study
Control Clin Trials
(2002) - et al.
Telephone counseling helps maintain long-term adherence to a high-vegetable dietary pattern
J Nutr
(2007) - et al.
Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women's Healthy Eating and Living Study
Am J Clin Nutr
(2009) Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition. Institute of Food Technologists, and International Food Information Council
Am J Clin Nutr
(2009)Cancer facts and figures
(2009–2010)Food, nutrition and the prevention of cancer: a global perspective
(2007)
Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk
J Natl Cancer Inst
Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
Breast Cancer Res Treat
Repeated measures of serum glucose and insulin in relation to postmenopausal breast cancer
Int J Cancer
Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study
J Clin Oncol
Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA.14 adjuvant breast cancer trial
2006 ASCO annual meeting proceedings (post-meeting edition)
J Clin Oncol
Cancer-related inflammation
Nature
Inflammation in atherosclerosis
Nature
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease
N Engl J Med
Soluble adhesion molecules and prediction of coronary heart disease: a prospective study and meta-analysis
Lancet
Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis
Cancer Causes Control
Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients
J Clin Oncol
Obesity and cancer: pathophysiological and biological mechanisms
Arch Physiol Biochem
Effect of exercise on serum estrogens in postmenopausal women: a 12-month randomized clinical trial
Cancer Res
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial
JAMA
Dietary composition and weight loss: can we individualize dietary prescriptions according to insulin sensitivity or secretion status?
Nutr Rev
Components of the Mediterranean-type food pattern and serum inflammatory markers among patients at high risk for cardiovascular disease
Eur J Clin Nutr
Prospective cohort study of lifetime physical activity and breast cancer survival
Int J Cancer
Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study
Cancer Epidemiol Biomarkers Prev
Greater survival after breast cancer in physically active women with high vegetable–fruit intake regardless of obesity
J Clin Oncol
Physical activity and survival after breast cancer diagnosis
JAMA
Insulin, macronutrient intake, and physical activity: are potential indicators of insulin resistance associated with mortality from breast cancer?
Cancer Epidemiol Biomarkers Prev
Exercise activity, body size and premenopausal breast cancer survival
Br J Cancer
Physical activity and survival after diagnosis of invasive breast cancer
Cancer Epidemiol Biomarkers Prev
Influence of pre- and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study
J Clin Oncol
Cited by (192)
Targeted nanomedicine delivery to human epidermal growth receptor
2022, Targeted Nanomedicine for Breast Cancer Therapy